A novel breakthrough US patented invention of Dr. M.S. Reddy to prevent or treat global COVID-19 infection

Good news to citizens of Colorado, United States, and the entire world, that a new invention to prevent or cure COVID-19 has been approved and patent granted by the United States Patent Office on August 3, 2021. The inventor is Dr. Malireddy S. Reddy aka Dr. M.S. Reddy. We can be proud that a Coloradan and a US citizen came up with such a breakthrough, patented invention to prevent and cure COVID-19 infection due to SARS-CoV-2 coronavirus.
According to Kyle W. Rost, a Denver, Colorado based U.S. patent attorney, who represented Dr. Reddy in the patent, Dr. Reddy’s invention has a new solution to the problems of this pandemic. Attorney Rost has represented Dr. Reddy over four decades, resulting in national and international patent protection. Dr. Reddy’s current treatment is designed to disrupt the fatty ball so often seen in pictures of the virus. This disruption prevents the virus from spreading. Vaccines operate differently, by producing antibodies within our immune systems that attack the spike proteins that extend from the fatty ball. Unfortunately, COVID-19 virus mutates continuously, making it impossible to contain the infection with just a first wave vaccine. So far, the world has registered mutants in the UK, South Africa, and Brazil, and currently a delta variant is spreading wildly. Thus, the future effectiveness of the existing first wave vaccines is questionable. In addition, there is no proven treatment modality for COVID-19 other than treating the symptoms. Unfortunately, the vaccine approach of attacking the spikes is not a reliable solution, because the mutations alter the composition of the spikes, which can reduce the effectiveness of the vaccines.
Dr. Reddy’s treatment is easy to administer through a sinus flush, a mouthwash, a nasal inhalation, or even by ingesting the preparation. The treatment uses all natural probiotics along with their immunomodulins, surfactants, antioxidants etc. The new invention will work by itself and can also be used along with the vaccinations as an adjuvant. Dr. Reddy gave over 15 webinars during the years 2020 and 2021, covering the world to educate the people with regard to curtailing the COVID-19 pandemic. He has been on over 15 different TV channels and was applauded by entire world for giving confidence to people. Millions of viewers have visited his internet site, leaving great compliments. Dr. Reddy has strongly advocated improvement of immunity, as a super aid to curtail COVID-19 infections, through proper maintenance of human microbiota by infusing all natural multiple mixed strain probiotics. Several million people are practicing the principles of his invention to improve their immunity. Dr. Reddy’s newest United States patent in biotechnology Patent #11,077,052. Dr. Reddy is moving forward to make his treatments available This is great news for the entire world to have hope and to gain confidence to override COVID-19 pandemic.
COVID-19 has literally destroyed the worldwide economy as well as the morale of the people. Since the start of the COVID-19 pandemic, it has infecting people in over 220 countries. Johns Hopkins University Center for Systems Science and Engineering reports there have been roughly 200 million cases with confirmed deaths of over 4.25 million. Unfortunately, the United States has registered a large portion of the COVID cases i.e., 35,303,779 with confirmed deaths of 614,705.
Dr. Malireddy S. Reddy has degree in Veterinary medicine and also MS and Ph.D. degrees in microbiology, bacteriology, virology, and food technology. He currently serves as CEO and President of ADFAC Labs, Inc. and IMAC Inc., located in Denver, Colorado. In addition to his national and international patents, he has received over 160 national and international awards for his scientific contributions, which have direct application to humanity at large. He lives in Cherry Hills Village along with his wife Syama. The couple has two children, daughter Deepa and son Sridhar.